Sorafenib and Lorazepam drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Sorafenib (sorafenib) and Lorazepam (lorazepam). Common drug interactions include drug ineffective among females and pneumonia among males.
The phase IV clinical study analyzes what interactions people have when they take Sorafenib and Lorazepam. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.
What is Sorafenib?
Sorafenib has active ingredients of sorafenib. eHealthMe is studying from 3,201 Sorafenib users. Check the latest studies of Sorafenib.
What is Lorazepam?
Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
30 people who take Sorafenib and Lorazepam together, and have interactions are studied.

What are the common drug interactions of Sorafenib and Lorazepam, by gender? *:
female:
- Drug ineffective
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Fatigue (feeling of tiredness)
- Incisional drainage
- Liver disorder (liver diseases)
- Lymphadenopathy (disease or enlargement of lymph nodes)
- Nodule (a growth of abnormal tissue)
- Overdose
- Pulmonary embolism (blockage of the main artery of the lung)
- Skin lesion
male:
- Pneumonia
- Death
- Lung disorder (lung disease)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Alanine aminotransferase increased
- Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
- Diplegia (paralysis of corresponding parts on both sides of the body)
- Hypoventilation (too shallow or too slow breathing, which does not meet the needs of the body)
- Urinary retention (the inability to completely or partially empty the bladder)
What are the common drug interactions of Sorafenib and Lorazepam, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Headache (pain in head)
- Hypotension (abnormally low blood pressure)
- Leukaemia recurrent (repeat cancer of bone marrow or blood cells)
- Nausea (feeling of having an urge to vomit)
- Rash
- Anal abscess
- Drug ineffective
- Febrile neutropenia (fever with reduced white blood cells)
- Incisional drainage
- Lymphadenopathy (disease or enlargement of lymph nodes)
30-39:
n/a
40-49:
- Aspergilloma (fungus ball, is a clump of fungus which exists in a body cavity such as the lung)
- Pneumonia
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Sepsis (a severe blood infection that can lead to organ failure and death)
50-59:
- Migraine (headache)
- Mitral valve incompetence (inefficient heart valve)
- Pleural effusion (water on the lungs)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Death
- Headache (pain in head)
- Alanine aminotransferase increased
- Anaemia (lack of blood)
- Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
- Diplegia (paralysis of corresponding parts on both sides of the body)
60+:
- Pneumonia
- Asthenia (weakness)
- Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
- Hypokalaemia (low potassium)
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
- Hypoxia (low oxygen in tissues)
- Lung disorder (lung disease)
- Toxic encephalopathy (a degenerative neurologic disorder caused by exposure to toxic substances)
- Tremor (trembling or shaking movements in one or more parts of your body)
- Acute respiratory distress syndrome
What are the existing conditions these people have? *
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 8 people, 26.67%
- Pain: 4 people, 13.33%
- Nausea (feeling of having an urge to vomit): 4 people, 13.33%
- Insomnia (sleeplessness): 4 people, 13.33%
- Nausea And Vomiting: 3 people, 10.00%
- Hepatocellular Carcinoma (liver cancer): 3 people, 10.00%
- Rhabdomyosarcoma (cancer of the bone, soft tissues, or connective tissue (e.g., tendon or cartilage)): 2 people, 6.67%
- Pancreatic Carcinoma (pancreatic cancer): 2 people, 6.67%
- Neoplasm Malignant (cancer tumour): 2 people, 6.67%
- Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 2 people, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Sorafenib and Lorazepam?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Sorafenib and Lorazepam:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Sorafenib:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lorazepam:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Sorafenib and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lorazepam and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .
- Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on sorafenib and lorazepam (the active ingredients of Sorafenib and Lorazepam, respectively), and Sorafenib and Lorazepam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Meloxicam and Myocardial Infarction for Men aged 60+ - 2 seconds ago
- Meloxicam and Mi for Men aged 60+ - 3 seconds ago
- Meloxicam and Acute Mi for Men aged 60+ - 3 seconds ago
- Meloxicam and Heart Attack for Men aged 60+ - 3 seconds ago
- Warfarin Sodium and Hepatic Neoplasm Malignant for Women aged 60+ - 4 seconds ago
- Lopressor and Zolpidem drug interactions for women aged 40-49 - 8 seconds ago
- Chlorhexidine Gluconate and Dilaudid drug interactions for women aged 30-39 - 9 seconds ago
- Wound and drugs of ingredients of betamethasone valerate - 14 seconds ago
- Could Abilify cause Swallowing Difficulty? - 16 seconds ago
- Could Jakafi cause Cough? - 16 seconds ago